ClinicalTrials Identifier: NCT00070109
Updated: 2010_11_05
Descriptive Information
Brief title Ecteinascidin 743 in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
Official title A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcoma
Recruitment Information
Status Completed
Start date 2008-01
Primary completion date 2010-10 (Actual)
Administrative Data
Organization name National Cancer Institute (NCI)
Organization study ID CDR0000329999
Secondary ID COG-ADVL0221
Sponsor Children's Oncology Group
Collaborator National Cancer Institute (NCI)
Health Authority United States: Federal Government
...